- Home
- SYPR vs NRSN Comparison
SYPR vs NRSN Comparison
Compare SYPR & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYPR
- NRSN
- Stock Information
- Founded
- SYPR 1997
- NRSN 2017
- Country
- SYPR United States
- NRSN Israel
- Employees
- SYPR N/A
- NRSN N/A
- Industry
- SYPR Industrial Machinery/Components
- NRSN Biotechnology: Pharmaceutical Preparations
- Sector
- SYPR Industrials
- NRSN Health Care
- Exchange
- SYPR Nasdaq
- NRSN Nasdaq
- Market Cap
- SYPR 31.2M
- NRSN 26.3M
- IPO Year
- SYPR 1994
- NRSN 2021
- Fundamental
- Price
- SYPR $1.38
- NRSN $0.90
- Analyst Decision
- SYPR
- NRSN
- Analyst Count
- SYPR 0
- NRSN 0
- Target Price
- SYPR N/A
- NRSN N/A
- AVG Volume (30 Days)
- SYPR 15.8K
- NRSN 197.5K
- Earning Date
- SYPR 11-12-2024
- NRSN 12-03-2024
- Dividend Yield
- SYPR N/A
- NRSN N/A
- EPS Growth
- SYPR N/A
- NRSN N/A
- EPS
- SYPR N/A
- NRSN N/A
- Revenue
- SYPR $141,466,000.00
- NRSN N/A
- Revenue This Year
- SYPR N/A
- NRSN N/A
- Revenue Next Year
- SYPR N/A
- NRSN N/A
- P/E Ratio
- SYPR N/A
- NRSN N/A
- Revenue Growth
- SYPR 7.82
- NRSN N/A
- 52 Week Low
- SYPR $1.27
- NRSN $0.51
- 52 Week High
- SYPR $2.30
- NRSN $2.33
- Technical
- Relative Strength Index (RSI)
- SYPR 43.06
- NRSN 25.71
- Support Level
- SYPR $1.34
- NRSN $1.23
- Resistance Level
- SYPR $1.47
- NRSN $1.34
- Average True Range (ATR)
- SYPR 0.08
- NRSN 0.08
- MACD
- SYPR 0.01
- NRSN -0.05
- Stochastic Oscillator
- SYPR 43.75
- NRSN 9.91
About SYPR Sypris Solutions Inc.
Sypris Solutions Inc is a USA-based company engaged in providing truck components, oil and gas pipeline components, and aerospace and defense electronics. The company offers a range of manufacturing, engineering, design, and other technical services. The business activity of the firm is functioned through Sypris Technologies and Sypris Electronics segments. Sypris Technologies segment is engaged in the sale of machined, welded, and heat-treated steel components for heavy commercial vehicle and high-pressure energy pipeline applications whereas the Sypris Electronics segment is engaged in the sale of manufacturing services, technical services, and products to customers in the market for aerospace and defense electronics. Sypris derives the revenue from the Technologies segment.
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.